secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2026-06-01T10:56:36+00:00
Accession:  0001193125-26-249684
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio enters new ATM equity facility with JonesTrading, terminates prior Cantor agreement
--------------------------------------------------------------------------------

- Entered Capital on Demand Sales Agreement with JonesTrading for at-the-market offerings of common stock.
- Agent receives 3.0% commission on gross proceeds; no obligation to sell; company may terminate on 10 days' notice.
- Terminated prior Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective May 29, 2026, with no penalties.
- New ATM program registered under Form S-3 (File No. 333-291393); shares sold via Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/0001193125-26-249684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/d100941d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-249684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer